Medical Oncology

Prof. Dr. Okan Kuzhan

Doctor and researcher Acıbadem Kozyatağı Hastanesi İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
  • Beyin Tümörleri
  • Lenfoma (Hodgkin Lenfoma ve Hodgkin Dışı Lenfoma)
  • Mide Kanseri
  • Yumurtalık (Over) Kanseri
  • Meme Kanseri
  • Prostat Kanseri
  • Jinekolojik Tümörler ve Kanserler (Rahim, Serviks, Yumurtalık/Over Kanseri vb.)
  • Kolorektal Kanserler (Kolon ve Rektum Kanseri)
  • Akciğer Kanseri
  • Lenf Kanseri (Lenfoma)
  • Kolon (Kalın Bağırsak) Kanseri

CV

Education and experience

From source

Experience

  • 2014Acıbadem Sağlık Grubuacibadem.com.tr
  • 2005 - 2012GATA Tıbbi Onkoloji Bilim Dalıacibadem.com.tr
  • 1994 - 1996TC Donanma Komutanlığı, Akü Batarya Fabrikasıacibadem.com.tr

Education

  • 2009Gülhane Askeri Tıp Akademisi Askeri Tıp Fakültesi, Doçent, Digeracibadem.com.tr
  • 2004Gülhane Askeri Tıp Akademisi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2000Gülhane Askeri Tıp Akademisi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 1993Gülhane Askeri Tıp Akademisi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Kozyatağı Hastanesiacibadem.com.trFrom source
  • Publications10 publicationsacibadem.com.tr profile pageFrom source
  • Last synchronised4 November 2026 21:15https://www.acibadem.com.tr/doktor/okan-kuzhan/acibadem.com.tr

Scientific work

Publications

10 publications

  1. Gemsitabinin multipl myelom (RPMI-8226) ve IgG plazma hücreli lösemi (ARH 77) hücre hatları üzerindeki sitotoksik etkisi

    Source: acibadem.com.tr profile page

  2. Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain.

    Source: acibadem.com.tr profile page

  3. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.

    Source: acibadem.com.tr profile page

  4. Factors affecting engraftment time in autologous peripheral stem cell transplantation.

    Source: acibadem.com.tr profile page

  5. Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicin- and trastuzumab-induced cardiotoxicity.

    Source: acibadem.com.tr profile page

  6. Modified outpatient dexamethazone, cytarabine and cisplatin regimen may lead to high response rates and low toxicity in lymphoma.

    Source: acibadem.com.tr profile page

  7. Filariasis as acause of subileus and death in a patient with solid tumor

    Source: acibadem.com.tr profile page

  8. A Cohort Study of Adult Rhabdomyosarcoma: A Single Institution Experience

    Source: acibadem.com.tr profile page

  9. Applying G-CSF on post-transplant +5th day is advantageous on supportive treatment in patients undergoing peripheral blood stem cell transplantation

    Source: acibadem.com.tr profile page

  10. Ekstragonadal germ hücreli tümörler

    Source: acibadem.com.tr profile page